1. $FOLD vs. $INFI vs. $HPTX vs. $ENTA Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=FOLD|INFI|HPTX|ENTA|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  2. $AMRN vs. $SPPI vs. $HPTX vs. $INFI Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=AMRN|SPPI|HPTX|INFI|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  3. $FOLD vs. $HPTX vs. $INFI vs. $AEGR Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=FOLD|HPTX|INFI|AEGR|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  4. $FOLD vs. $AEGR vs. $INFI vs. $ENTA Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=FOLD|AEGR|INFI|ENTA|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  5. $FOLD vs. $INFI vs. $HPTX Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=FOLD|INFI|HPTX|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  6. $AMRN vs. $INFI vs. $HPTX vs. $ENTA Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=AMRN|INFI|HPTX|ENTA|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  7. $MNTA vs. $HPTX vs. $AEGR vs. $INFI Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=MNTA|HPTX|AEGR|INFI|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  8. $EXEL vs. $AEGR vs. $HPTX vs. $INFI Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=EXEL|AEGR|HPTX|INFI|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  9. $EXEL vs. $HPTX vs. $INFI vs. $ENTA Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=EXEL|HPTX|INFI|ENTA|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  10. $AMRN vs. $SPPI vs. $ENTA vs. $INFI Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=AMRN|SPPI|ENTA|INFI|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  11. $MNTA vs. $ENTA vs. $INFI Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=MNTA|ENTA|INFI|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  12. $FOLD vs. $INFI vs. $AEGR Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=FOLD|INFI|AEGR|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  13. $INFI Apr. 17, 2015 CALL 16.00 : +1.316 contracts add to OI

  14. IV30(TM) GAINER $ABMD +30.95% $BTX +30.47% $SONS +29.49% $ACHN +15.54% $INFI +15.41% $NSR +14.71% $ARRY +14.38% http://community.livevol.com/index.php/index.html

  15. Over 50 SMA http://www.dailystockplays.com/Over-50-SMA-2015-03-24.html $LPX $RRC $LINE $GPK $HA $NFLX $TVPT $TIF $CNI $WSM $WCC $CRZO $PENN $TRP $MTZ $UPL $INFI $PBPB $QIWI

  16. Unusually High Biotech Option Volume data via --> https://secure.livevol.com/trial/livevol-x-trial/registration-promo-order-flow?offer_code=LV_OFlow $BTX $INFI $RPTP $ARRY $ATHX $NLNK

  17. Scan results - 180 Bullish Setup today: $BRX $BDC $PBPB $TPH $INFI $TXT $BAM $YUM $HA $TRN ... http://swingtradebot.com/events/43/equities?selected_date=2015-03-24

  18. Scan results - Crossed Above 50 DMA today: $TVPT $MKC $PBPB $QIWI $WCC $WSM $INFI $BLCM $CNI $HA ... http://swingtradebot.com/events/1/equities?selected_date=2015-03-24

  19. TODAY S WISEGUY FLOW & UOA: http://www.optionjesus.com/recent-flow.html $TWTR $JD $HILL $NLNK $BTU $X $INFI $NVAX

  20. 10 most loved small biopharma stocks in ETF $BBC: $BLUE $RCPT $ACHN $FOLD $INFI $ALNY $CLVS $PTCT $ACAD $ARRY http://hedgemind.com/stocks/symbol?t=BLUE

  21. $INFI sweep 1100+ Apr $16 C

  22. $INFI APR 16 CALL BUYING 1287 bought on offer @$ .55

  23. $ISIS vs. $CBPO vs. $INFI Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=ISIS|CBPO|INFI&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  24. Williams Below -80 http://www.dailystockplays.com/Williams-Below--80-2015-03-22.html $MRVL $REXX $GALE $IMGN $LUK $FRO $BCRX $MTL $HDB $SRPT $CTAS $EXP $INFI $ENZN $RGLS $AVNW $LRN

  25. $INFI Any ideas why people are selling today? Oh well, I guess I shouldn t look a gift horse in the mouth.